Two founders, two halves of the machine.

Tomer Zilbershtein

Tomer Zilbershtein

CEO and Cofounder

Leads Reef’s biodesign and AI engineering. He has worked as an iOS engineer, built the data model for acquisition analysis at the Sanaby Health SPAC, and evaluated the technical, scientific, and regulatory feasibility of a biotech IP portfolio at iTolerance. He is a medical student at the University of Arizona, where he also researches space-medicine systems, mentored by the APEX aerospace surgery fellowship’s director.

Sahil Khan

Sahil Khan

CTO and Cofounder

Leads Reef’s lab-automation and production hardware. A Biomedical Engineering BS/MS candidate at Drexel (biomechanics, finance minor), he has engineered hardware as a commercialization and validation engineer at The Estée Lauder Companies and as a spacecraft-mechanisms co-op at the U.S. Naval Research Laboratory. He is president of Drexel IEEE and runs DragonHacks, Philadelphia’s largest student-run hackathon.

Zachary Brooks, PhD

Zachary Brooks, PhD

Advisor

Founder and CEO of UGenome AI, affiliated with the University of Arizona and the Wildcat Seed Fund. He brings company-building and investing experience to Reef.

Our vision.

We both believe the future of medicine is n=1: a therapy made for one patient and one infection. Making medicine one patient at a time only works if it is automated, so we started with the machine. Myx is our first step toward that future.

Help us outpace superbugs.

We're a small team building a machine that evolves medicine. If the work pulls at you, tell us what you'd bring.

01
Biology
Phage, microbiology, directed evolution.
02
Hardware
Automation, fluidics, mechanisms.
03
Software & AI
Control systems, models, data.
04
Clinical & regulatory
Partners, trials, the path to patients.
Where you'd fit · pick any
Or write to team@reef.bio